Assessing reporting completeness and characteristics in decentralized randomized controlled trials: a scoping review protocol.

ABSTRACT:

Background

With the development of remote technology, decentralized clinical trials have rapidly increased in recent years. Despite the comprehensive reporting guidance provided by the CONSORT 2025 guideline, decentralized randomized controlled trials still face specific reporting challenges. Therefore, we aim to evaluate the reporting characteristics and completeness of decentralized randomized controlled trials, using a specially designed checklist that has been extended according to the CONSORT 2025 original items.

Methods

We will search six databases (Embase, Ovid MEDLINE®, PubMed, CNKI, VIP, Wanfang) for decentralized randomized controlled trials published in Chinese or English during 2023. A pre-designed form will be used to extract general characteristics. Reporting c

SUBMITTER: Wang J 

PROVIDER: S-EPMC12836950 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature